Literature DB >> 11375267

New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.

C Patterson1, G A Stouffer, N Madamanchi, M S Runge.   

Abstract

Thrombin is a serine protease that potently activates platelets and catalyzes the conversion of fibrinogen to fibrin. Thrombin also exerts direct effects on vascular cells, such as smooth muscle cells, via interactions with members of the protease-activated receptor family. Evidence in several animal models implicates thrombin-mediated signaling events in the response to injury that typifies vascular lesion formation in atherosclerosis and restenosis. In this review, we examine the activation of protease-activated receptors by thrombin, the downstream signaling events mediated by these receptors, and the physiological role of thrombin in vascular cells and vascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375267     DOI: 10.1161/hh1001.091447

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

1.  Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.

Authors:  Claire J Chalmers; Kathryn Balmanno; Kathryn Hadfield; Rebecca Ley; Simon J Cook
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 2.  Role of G protein-coupled receptors in inflammation.

Authors:  Lei Sun; Richard D Ye
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

3.  Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.

Authors:  Michael Holinstat; Nancy E Colowick; Willie J Hudson; Dana Blakemore; Qingxia Chen; Heidi E Hamm; John H Cleator
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

4.  Modifiers of symptomatic embolic risk in infective endocarditis.

Authors:  Nandan S Anavekar; Jason C Schultz; Daniel D Correa De Sa; Justin M Thomas; Brian D Lahr; Imad M Tleyjeh; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

5.  Thrombin-induced glucose transport via Src-p38 MAPK pathway in vascular smooth muscle cells.

Authors:  Yasunari Kanda; Yasuhiro Watanabe
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells.

Authors:  Param Vidwan; Alokkumar Pathak; Samar Sheth; Jianhua Huang; Dougald M Monroe; George A Stouffer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-07       Impact factor: 8.311

7.  We can do it together: PAR1/PAR2 heterodimer signaling in VSMCs.

Authors:  Rafal Pawlinski; Michael Holinstat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12       Impact factor: 8.311

Review 8.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

9.  Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells.

Authors:  Martin Scholz; Jens-Uwe Vogel; Gerold Höver; Susanna Prösch; Ruslan Kotchetkov; Jaroslav Cinatl; Frank Koch; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

10.  Clinical use of topical thrombin as a surgical hemostat.

Authors:  Wesley K Lew; Fred A Weaver
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.